News

Ovid Therapeutics Sells Ganaxolone Royalty Rights for $7M to Immedica Pharma
Ovid Therapeutics Inc. (NASDAQ:OVID) is one of the best penny stocks under $1 to buy now. On June 25, Ovid Therapeutics ...
IPWatchdog1d
EPO Enlarged Board of Appeal Brings On-Sale Bar Doctrine Closer to United States’
The EPO Enlarged Board of Appeal has introduced a shift in European patent law’s treatment of publicly available products, especially where their composition is not fully disclosed or reproducible.
Verizon owes $175 million in patent infringement case, Texas jury says
A federal court in Marshall, Texas, said on Wednesday that U.S. telecom company Verizon Wireless must pay $175 million in ...
TipRanks on MSN1d
Pfizer completes licensing agreement with 3SBio
China, licensing agreement with 3SBio, granting Pfizer exclusive rights for the development, manufacturing and commercialization of 3SBio’s SSGJ-707, a bispecific antibody targeting PD-1 and VEGF ...
IPWatchdog2d
Tulip Innovation Obtains Additional Battery Patent Injunction against Sunwoda Group
Budapest,: On 17 July 2025, Tulip Innovation won another injunction in German litigation concerning battery electrode and ...
JD Supra2d
IP Hot Topic: A Clash in California: Judicial Tug of War Between the Primacy of Transformative Use and Market Effect in GenAI Fair Use Cases
Summer Associate Wade Marshall contributed to this article. Recently, two Northern District of California decisions ...
Training Alone Is Not Enough: Lessons From 'Recentive' and USPTO AI Examples on Patent Eligible Machine-Learning Claims
The Recentive decision exemplifies the Federal Circuit’s skepticism toward claims that dress up longstanding business problems in machine-learning garb, while the USPTO’s examples confirm that ...